Please join the AAPS Bioanalytical Community on Oct 8th@ noon EDT for an Open Scientific Discussion:
Killing or not killing: Nab assay format for ADC
Since the primary mechanism of action (MOA) of antibody-drug conjugates (ADCs) in vivo is to eliminate cancer cells, should a cell-killing neutralizing antibody (NAb) assay be established as the standard approach? What challenges might arise in developing a cell-killing NAb assay for ADCs, and what additional insights could such an assay offer?
Presenter: Weifeng Xu (Merck)
Moderator: Sanjeev Bhardwaj (Moderna)
Have an idea for an upcoming session?
Please contact the OSD Committee Co-Chairs, @Sanjeev Bhardwaj & @Laurelle Calliste
We start at noon EST sharp. To avoid interruptions, please dial in before noon and mute yourself until the Q&A starts.
(Please remain on mute and submit your questions via the Chat feature of GoToMeeting)
Please join from your computer, Tablet, or smartphone.
https://meet.goto.com/BA-OSD
You can also dial in using your phone.
Access Code: 871-534-861
United States: +1 (571) 317-3122
Join from a video-conferencing room or system.
Meeting ID: 871-534-861
Dial in or type: 67.217.95.2 or inroomlink.goto.com
Or dial directly: [email protected] or 67.217.95.2##871534861
Get the app now and be ready when your first meeting starts:
https://meet.goto.com/install
https://www.linkedin.com/events/osdforumonneutralizingantibodya7245547762249793536/
#bioanalysis #Bioanalytical #OSD #OpenScientificDiscussions
------------------------------
Sanjeev Bhardwaj
Moderna Therapeutics
Cambridge, MA.
[email protected]Disclaimer: Opinions expressed are solely my own and do not express the views or opinions of my employer.
------------------------------